Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets

This study has been completed.
Information provided by:
Mylan Pharmaceuticals Identifier:
First received: March 30, 2008
Last updated: March 31, 2008
Last verified: March 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2007
  Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)